Lin, Jiayuh

A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells

Song, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences

Cytokine Signaling Pathways and InteractionsComputational Drug Discovery Methods

Cited by 504

Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival

Chen, C.-L., Cen, L., Kohout, J., Hutzen, B., Chan, C., Hsieh, F.-C., Loy, A., Huang, V., Cheng, G., & Lin, J. (2008) · Molecular Cancer

Cytokine Signaling Pathways and InteractionsBladder and Urothelial Cancer Treatments

Cited by 125

Analysis of Wild-Type and Mutant p21 WAF-1 Gene Activities

Lin, J., Reichner, C., Wu, X., & J. Levine, A. (1996) · Molecular and Cellular Biology

Cancer-related Molecular PathwaysSignaling Pathways in Disease

Cited by 111

Expression of Concern: A small molecule, LLL12 inhibits constitutive STAT3 and IL‐6‐induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells

Lin, L., Benson, D. M., DeAngelis, S., Bakan, C. E., Li, P., Li, C., & Lin, J. (2012) · International Journal of Cancer

Cytokine Signaling Pathways and InteractionsMultiple Myeloma Research and Treatments

Cited by 66

Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma

Yu, P. Y., Gardner, H. L., Roberts, R., Cam, H., Hariharan, S., Ren, L., LeBlanc, A. K., Xiao, H., Lin, J., Guttridge, D. C., et al. (2017) · PLOS ONE

Cytokine Signaling Pathways and InteractionsSarcoma Diagnosis and Treatment

Cited by 17